Predictions
Waberers International Plc
Start price
Target price
Perf. (%)
€6.96
24.10.23
24.10.23
-
24.10.24
24.10.24
47.99%
20.05.24
20.05.24
Sunworks Inc.
Start price
Target price
Perf. (%)
€0.36
20.10.23
20.10.23
€1.00
20.10.24
20.10.24
-45.93%
15.05.24
15.05.24
Revenue growth >5% per year expected
Top 10 in its market
Small cyclical dependencies
Known brand
Instone Real Estate Group AG
Start price
Target price
Perf. (%)
€5.45
19.10.23
19.10.23
-
19.10.24
19.10.24
69.72%
20.05.24
20.05.24
Schott Pharma AG & Co. Kgaa
Start price
Target price
Perf. (%)
€30.78
06.10.23
06.10.23
-
06.10.24
06.10.24
-0.84%
20.05.24
20.05.24
Upstart Holdings Inc.
Start price
Target price
Perf. (%)
€27.04
01.10.23
01.10.23
€30.00
01.10.24
01.10.24
-13.93%
20.05.24
20.05.24
Good rating
Good culture
Few uniques
Low dividend yield expected
Cannabist Company Holdingsinc
Start price
Target price
Perf. (%)
€0.86
29.09.23
29.09.23
-
29.09.24
29.09.24
-70.67%
20.05.24
20.05.24
Super League Enterprise Inc.
Start price
Target price
Perf. (%)
€2.48
22.09.23
22.09.23
-
22.09.24
22.09.24
-
12.09.23
12.09.23
Precision BioSciences Inc
Start price
Target price
Perf. (%)
€0.39
19.09.23
19.09.23
€2.81
19.09.24
19.09.24
-11.92%
13.02.24
13.02.24
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.26
18.09.23
18.09.23
€1.00
18.09.24
18.09.24
-22.31%
20.05.24
20.05.24
Differentiated customer and product portfolio
Leading role in innovation
Revenue growth > 30% per year expected
Higher risks for its business
Dianthus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.14
16.09.23
16.09.23
-
16.09.24
16.09.24
115.44%
20.05.24
20.05.24
Columbia Care Inc.
Start price
Target price
Perf. (%)
€1.05
09.09.23
09.09.23
€1.30
09.09.24
09.09.24
14.29%
20.11.23
20.11.23
Capable Management
Innovative
Bad rating
Few uniques
Traction Uranium Corp.
Start price
Target price
Perf. (%)
€0.25
01.09.23
01.09.23
€1.00
01.09.24
01.09.24
-81.12%
20.05.24
20.05.24
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Sensei Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€0.93
26.08.23
26.08.23
€0.90
26.08.24
26.08.24
53.89%
20.05.24
20.05.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
Phunware Inc.
Start price
Target price
Perf. (%)
€0.28
26.08.23
26.08.23
€0.10
26.08.24
26.08.24
-43.93%
26.02.24
26.02.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Vidac Pharma Holding Plc
Start price
Target price
Perf. (%)
€1.30
26.08.23
26.08.23
€2.00
26.08.24
26.08.24
-86.15%
20.05.24
20.05.24